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Abstract
Background: Obesity is one of the most important medical and public health problems of our time: it increases the 
risk of many health complications such as hypertension, coronary heart disease and type 2 diabetes, needs long-lasting 
treatment for effective results and involves high public and private costs. Therefore, it is imperative that enduring and 
low-cost clinical programs for obesity and related co-morbidities are developed and evaluated.
Methods/Design: TECNOB (TEChnology for OBesity) is a comprehensive two-phase stepped down program 
enhanced by telemedicine for the long-term treatment of obese people with type 2 diabetes seeking intervention for 
weight loss. Its core features are the hospital-based intensive treatment (1-month), that consists of diet therapy, 
physical training and psychological counseling, and the continuity of care at home using new information and 
communication technologies (ICT) such as internet and mobile phones. The effectiveness of the TECNOB program 
compared with usual care (hospital-based treatment only) will be evaluated in a randomized controlled trial (RCT) with 
a 12-month follow-up. The primary outcome is weight in kilograms. Secondary outcome measures are energy 
expenditure measured using an electronic armband, glycated hemoglobin, binge eating, self-efficacy in eating and 
weight control, body satisfaction, healthy habit formation, disordered eating-related behaviors and cognitions, 
psychopathological symptoms and weight-related quality of life. Furthermore, the study will explore what behavioral 
and psychological variables are predictive of treatment success among those we have considered.
Discussion: The TECNOB study aims to inform the evidence-based knowledge of how telemedicine may enhance the 
effectiveness of clinical interventions for weight loss and related type-2 diabetes, and which type of obese patients 
may benefit the most from such interventions. Broadly, the study aims also to have a effect on the theoretical model 
behind the traditional health care service, in favor of a change towards a new "health care everywhere" approach.
Trial registration: Current Controlled Trials ISRCTN07265661
Background
Since 1997, when the World Health Organization (WHO)
described obesity as a chronic pathology with such an
increasing incidence that it can be defined as a global epi-
demic, obesity is still an increasingly worrying issue for
public health authorities. In 2005, about 1.6 billion adults
(above 15 years of age) were estimated to be overweight,
whereas about 400 million people were obese. WHO fur-
ther projects that by 2015, approximately 2.3 billion
adults will be overweight and more than 700 million will
be obese [1]. Obesity is associated with early death [2,3]
and is universally recognized as a risk factor for many
health complications such as cardiovascular diseases,
some types of cancer, osteoarthritis, hypertension, dyslip-
idemia, hypercholesterolemia and diabetes. Obesity is a
strong risk factor for the development of type II diabetes
[4,5]. Indeed, as BMI (Body Mass Index) increases, the
risk of developing type 2 diabetes increases in a "dose-
dependent" manner [6,7]. The prevalence of type 2 diabe-
tes is 3-7 times higher in obese than in normal-weight
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adults, and those with a BMI >35 are 20 times more likely
to develop type 2 diabetes than those with a BMI between
18.5 and 24.9 [8,9].
Given that obesity and associated type 2 diabetes lead
to serious health consequences that in turn weigh heavily
on public health care costs, developing effective interven-
tions for substantially reduce weight, maintain weight
loss and prevent or manage associated diseases like type 2
diabetes is compelling.
Stand-alone and combined treatment options (dietetic,
nutritional, physical, behavioral, cognitive-behavioral,
pharmacological, surgical) are available for both clinical
and community populations, but clinical practice and
research have shown significant difficulties with regard to
availability, costs, treatment adherence and long-term
efficacy [10]. From a public health strategy point of view,
many problems are due to the high costs of these proce-
dures, overall within an enduring care setting. Indeed, the
main challenge in the treatment of obesity is to maintain
weight loss in the long term [11]. Most overweight and
obese individuals regain about one third of the weight
lost with treatment within 1 year, sometimes even before
the end of the intervention, and they are typically back to
baseline in 3 to 5 years [12-14]. Similarly, few patients
with diabetes go on taking their prescribed medication
entirely as intended [15,16].
As suggested by Katan (2009) with regard to dieting,
cognitions and feelings have a huge impact on behavior
and may thus strength as well as disrupt adherence to
treatment and compliance with clinical prescriptions.
Indeed, psychological factors and processes mediate
every behavior change and differently affect both the ini-
tiation and maintenance phases [17]. According to Ryan
et al. [18], there are many approaches that have proved to
be effective in initiating change, from external pressure
and control to the positive use of incentives or rewards,
but the ingredients essential to maintenance are still
missing.
Enduring and cost-effective approaches that can reach
broad populations of obese people are thus needed and
have to be evaluated overall with regard to compliance
and healthy behavior maintenance in the long term. A
new promising method for granting continuity of care to
wide populations of patients at low costs is telemedicine
and its more specific branches called "e-therapy", "tele-
care" and "e-health": information and telecommunication
technologies (ICT) used in order to exchange informa-
tion useful for the diagnosis, treatment, rehabilitation
and prevention of diseases [19,20]. Telecare can be car-
ried out with tools such as web-sites, e-mail, chat lines
(e.g. IRC, internet relay chat), videoconference, telephone
and UMTS-based mobile-phone [21]. As already indi-
cated in several studies [22-26], treatments delivered by
ICT may be valid alternatives to reduce expensive and
time-consuming clinical visits and to improve adherence
to prescribed treatment through extensive monitoring
and support.
For these reasons, we developed TECNOB (TEChnol-
ogy for OBesity), a comprehensive two-phase stepped
down program enhanced by telecare for the long-term
treatment of obese people with type 2 diabetes seeking
intervention for weight loss [27]. The core aspects of
TECNOB are the hospital-based intensive treatment and
the continuity of care at home using new information and
communication technologies (ICT) such as internet and
mobile phones. ICT-based approaches have already been
shown to be helpful in weight loss and long-term mainte-
nance [10,12,28-32], but much more work remains to be
carried out in order to confirm these findings. Further-
more, very few studies have investigated the effects of an
ICT-based program on obese patients with established
type 2 diabetes and to our knowledge no study has tested
a comprehensive long-term stepped down intervention
starting with 1-month hospitalization specifically
addressed to weight loss.
TECNOB protocol was mainly framed within the self-
determination theoretical model of behavior change [33]
and thus emphasizes the importance of maximizing the
patients' experience of autonomy, competence and relat-
edness for the successful maintenance of behavior change
[18].
This paper describes the design of the TECNOB study,
a two-arm randomized controlled trial (RCT). The aims
of this study are to evaluate the effectiveness of the TEC-
NOB program in a sample of obese people with type 2
diabetes seeking treatment for weight reduction and to
find out what behavioral and psychological variables are
predictive of treatment success.
Methods/Design
Design
The effectiveness of the TECNOB program will be
assessed in a two-arm randomized controlled trial. Par-
ticipants will be randomly allocated in 2 groups:
1) TECNOB group: in-hospital treatment (diet, physi-
cal activity, psychological and dietitian counseling) plus
extensive outpatient telecare through a web-platform and
mobile phones;
2) CONTROL group: in-hospital treatment (diet, phys-
ical activity, psychological and dietitian counseling) and
follow-up assessment at the 3rd, 6th and 12th month;
The Medical Ethics Committee of Istituto Auxologico
Italiano approved the study protocol.
Intervention
The TECNOB clinical program has a total duration of 13
months and consists of two stepped down phases: in-
patient (1 month) and out-patient (the following 12Castelnuovo et al. BMC Public Health 2010, 10:204
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months). During the in-patient phase, participants
undergo an intensive four-week hospital-based and medi-
cally-managed program for weight reduction and rehabil-
itation. Along this period, participants live in a medical
hospital-like environment located on a mountain high-
land and far away from towns and cities. Visits from par-
ents are allowed only in the afternoon. All patients are
placed on a hypocaloric nutritionally balanced diet tai-
lored to the individual after consultation with a dietitian
(energy intake around 80% of the basal energy expendi-
ture estimated according to the Harris-Benedict equation
and a macronutrient composition of about 16% proteins,
25% fat and 59% carbohydrates). Furthermore, they
receive nutritional counseling provided by a dietitian,
psychological counseling provided by a clinical psycholo-
gist and have physical activity training provided by a
physiotherapist.
Nutritional rehabilitation program aims to improve and
promote change in eating habits and consists of both
individual sessions (dietary assessment, evaluation of
nutrient intake and adequacy, nutritional status, anthro-
pometric, eating patterns, history of overweight, readi-
ness to adopt change) and group sessions (45 minutes
each twice a week) including: information on obesity and
related health risks, setting of realistic goals for weight
loss, healthy eating in general, general nutrition and core
food groups, weight management and behavior change
strategies for preventing relapse).
Psychological counseling is provided once a week both
individually and in group setting. Individual sessions,
lasting 45 minutes each, are mainly based on the cogni-
tive-behavioral approach described by Cooper and Fair-
burn [34] and emphasize the techniques of self-
monitoring, goal setting, time management, prompting
and cueing, problem solving, cognitive restructuring,
stress management and relapse prevention. Group ses-
sions ("closed" groups of 5/6 persons), lasting 1 hour
each, focus on issues such as motivation, assertiveness,
self-esteem, self-efficacy and coping.
Physical activity takes place once a day except for week-
end and consists of group programs (20 subjects) based
on postural gymnastics, aerobic activity and walks in the
open. Inpatients with specific orthopedic complications
carry out individual activities planned by physiothera-
pists and articulated in programs of physical therapy,
assisted passive and active mobilization and isokinetic
exercise.
Low to moderate weight losses are expected at the end
of the in-patient phase, but it is important to note that
weight loss is not the primary goal of the in-patient pro-
gram and each patient is made clear about this point at
the very beginning of the treatment. Beyond the medical
management of metabolic risk factors for health such as
type 2 diabetes, developing a sense of autonomy and
competence are the primary purposes of the in-hospital
interventions. Patients are afforded the skills and tools for
change and are supported in assigning positive values to
healthy behaviors and also in aligning them with personal
values and lifestyle patterns.
In the last week, just before discharge from hospital,
participants are instructed for the out-patient phase of
the program. They receive a multisensory armband
(SenseWear®  Pro2 Armband), an electronic tool that
enables automated monitoring of total energy expendi-
ture (calories burned), active energy expenditure, physi-
cal activity duration and levels (METs) and sleep/wake
states duration. Patients are instructed to wear this device
on the back of the upper arm and to record data for 36
hours every two weeks in a free-living context. The Arm-
band holds up to 12 days of continuous data which the
outpatients are instructed to download into their per-
sonal computer and to transmit online to a web-site spe-
cifically designed for data storing. Outpatients are also
told that they can review their progress using the InnerV-
iew® Software which analyzes and organizes data into
graphs and reports. Participants are then instructed to
use the TECNOB platform, an interactive web-site devel-
oped by TELBIOS S.P.A. http://www.telbios.it. The TEC-
NOB web-platform supports several functions and
delivers many utilities, such as questionnaires, an ani-
mated food record diary, an agenda and a videoconfer-
ence virtual room. In the "questionnaires" section,
patients fill in the Outcome Questionnaire [35] and sub-
mit data concerning weight and glycated hemoglobin. In
the "food record diary" participants submit actual food
intake day by day through the selection of food images
from a comprehensive visual database provided by
METEDA S.P.A. http://www.meteda.it. The same proce-
dure is also possible through a software called METADI-
ETA (Meteda s.p.a.) previously installed on the
outpatients' mobile phones before discharge. Through
the mobile phones outpatients maintain the contact with
the dietitian who regularly sends them SMS containing
syntax codes that METADIETA, the software previously
installed into the outpatients' mobile phones, uses in
order to visually display the food choices (frequency and
portions) outpatients have to adhere according to diet
prescriptions. By this way, outpatients can keep a food
record diary allowing comparisons between current eat-
ing and the recommended hypocaloric diet along the
whole duration of the program. The "agenda" allows the
patients to remember the videoconference appointments
with the clinicians and the days when to fill in the ques-
tionnaires. Moreover, the patients can use the "memo"
space to note down any important event occurred to him/
her in the previous week/month. Indeed, some research
indicates that changes in behavior (eating and exercise)
often follow discrete moments which have been variablyCastelnuovo et al. BMC Public Health 2010, 10:204
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described as life events, life crises, teachable moments or
epiphanies [36]. Life events can lead to weight loss but
also to weight gain and qualitative research shows that it
is not the event per se that results in behavior change but
the ways in which this event is appraised and interpreted
by the individual [37]. The clinical psychologist has thus
the opportunity to discuss with the outpatients about the
significant events reported in the "memo" space during
the videoconference sessions and cognitively reconstruct
dysfunctional appraisals in functional ways. Finally, out-
patients are instructed to use the videoconference tool.
Thanks to this medium, they receive nutritional and cog-
nitive-behavioral tele-counseling with the dietitian and
the clinical psychologist who attended the patients inside
the hospital. In particular, just after discharge, partici-
pants have 6 videoconference contacts with both clini-
cians along 3 months. From the 3rd to the 6th month
sessions are scheduled every 30 days and then even more
spaced up to an interval of 60 days. During tele-sessions,
clinicians (psychologist and dietitian) test the outpatients'
progress, their mood, the maintenance of the "good ali-
mentary and physical activity habits", the loss/increase of
weight and ask about critical moments, especially those
ones reported on the "memo" web-space. In particular,
tele-sessions with the clinical psychologist aim to consoli-
date strategies and abilities acquired during the in-patient
phase, to improve self-esteem and self-efficacy, to sup-
port motivation, to prevent relapse and to provide prob-
lem-solving and crisis counseling. On the other hand,
dietitian assesses adherence and compliance to dietary
therapy with a special focus on normal eating behavior,
sufficient fluid intake, hunger and fullness regulation,
appropriate eating/etiquette (pace and timing of meals),
slow rate of eating, and addresses critical points such as
plateau in weight loss or lack of readiness to improve
dietary habits.
In addition to videoconference, outpatients can further
contact clinicians by e-mail. Indeed, each patient is given
the possibility to join his clinician beyond the established
videoconference contacts in case of urgency or emer-
gency. According to the e-message's content, clinicians
choose the most appropriate format for delivering feed-
back among e-mail or telephone. In order to avoid exces-
sive dependence and to contain costs, a maximum
number of 1 not scheduled contact a week is established a
priori.
As described, in the outpatient phase of the TECNOB
program great relevance is given to the clinicians-patient
relationship as an important medium and vehicle of
change [18]. After discharge, out-patients begin to expe-
rience the autonomy and competence to change they
develop during the in-patient phase and inevitably face
resistances and barriers. Thanks to videoconferences,
out-patients are supported by the clinicians who attended
them during the in-hospital phase in exploring resis-
tances and barriers they experience and in finding func-
tional pathways to cope. Furthermore, out-patients are
helped to experience mastery in terms of the health
behavior change that needs to be engaged.
Participants in the control group will receive the hospi-
tal-based treatment and will be asked to respond to the
follow-up assessments. No contact will be maintained
with them at home and no continuous care will be pro-
vided after discharge.
Study population
Recruitment of the study population
All inpatients with obesity and type 2 diabetes in the age
range of 18-65 years who are referred to the S. Giuseppe
Hospital of the Istituto Auxologico Italiano for weight -
loss treatment will be asked and screened for admission
to the study.
Inclusion and exclusion criteria
Inpatients are eligible when they meet the following
inclusion criteria: 1) age between 18 and 65 years; 2) obe-
sity according to the WHO criteria (BMI ≥ 30); 3) type 2
diabetes mellitus; 4) Basic knowledge of informatics and
5) written and informed consent to participate. Exclusion
criteria for the study are: 1) severe psychiatric distur-
bance diagnosed by DSM- fourth revised criteria (ref.); 2)
concurrent medical condition not related to obesity.
SCID (Structured Clinical Interview for DSM-IV Dis-
orders) I and II (First, Gibbon, Spitzer, Williams, & Smith
Benjamin, 2007; First, Spitzer, Gibbon, & Williams, 2007)
are used as screening tools for psychiatric disorders and
are administered by an independent clinical psychologist
as part of his work.
Randomization procedure
All participants will be randomly assigned to the inter-
vention or control group. The randomization scheme will
be generated by using the Web site Randomization.com
http://www.randomization.com. Randomization will take
place after the baseline measurements.
Sample size calculation
The sample size calculation is based on a difference in
weight regain of 3 kg between the intervention and con-
trol group after 12 months. The standard deviation of
weight regain for the control group is considered to be 6
[12]. Based on these data, 64 participants per group are
needed to detect this difference with an alpha of 0.05
two-sided and a power of 0.80. We decided not to make
assumptions on sidedness because the TECHNOB pro-
gram may also have negative effects in comparison with
the control group. A sample of 154 persons (n = 77 per
group) is required taking into account a dropout rate of
20%.Castelnuovo et al. BMC Public Health 2010, 10:204
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Measurements
Primary outcome measure of the randomized trial is
weight in kilograms. Secondary outcome measures are
energy expenditure, glycated hemoglobin, binge eating,
self-efficacy in eating and weight control, body satisfac-
tion, healthy habit formation, disordered eating-related
behaviors and cognitions, psychopathological symptoms
and weight-related quality of life. Data will be collected at
baseline, at discharge from the hospital (c.a. 1 month
after) and after 3, 6 and 12 months from the end of the in-
hospital treatment.
Height and weight Height will be measured with a stadi-
ometer and weight will be assessed with the participant in
lightweight clothing with shoes removed on a balance
beam scale. Data collected at follow-up time points will
be self-reported. Weight and height will be used to calcu-
late BMI (weight in kilograms divided by the square of
height in meters).
Energy expenditure Energy expenditure is estimated
using a multisensory armband (SenseWear® Pro2 Arm-
band, BodyMedia, Inc.). A proprietary heat-flux sensor
measures the amount of heat being dissipated by the
body by measuring the heat loss along a thermally con-
ductive path between the skin and a vent on the side of
the armband. Skin temperature and near-armband tem-
perature are also measured by sensitive thermistors. The
armband also measures galvanic skin response (GSR - the
conductivity of the wearer's skin) which varies due to
physical and emotional stimuli. A two-axis accelerometer
tracks the movement of the upper arm and provides
information about body position. The armband also con-
tains a radio and a data port, allowing both wireless trans-
mission and communication as well as wired
downloading of data. SenseWear® Pro2 Armband is a cost-
efficient and simple solution that can be applied outside
the laboratory in a free-living environment to track
energy expenditure, physical activity durations and levels,
and lifestyle information. For more detailed information
on the armband and the algorithms it implements, visit
the web-site http://www.armband.it.
Glycated hemoglobin According to the Consensus
Statement on the Worldwide Standardization of the
Hemoglobin A1C Measurement [38], the hemoglobin
A1C (A1C) assay has become the gold-standard measure-
ment of chronic glycemia for over two decades. Anchored
in the knowledge that elevated A1C values increase the
likelihood of the micro-vascular complications of diabe-
tes (and perhaps macro-vascular complications as well),
the assay has become the cornerstone for the assessment
of diabetes care. In this study, we adopt the measurement
method (concentration of only one molecular species of
glycated A1C) and results reporting (mmol/mol and
derived NGSP %) developed by the International Federa-
tion of Clinical Chemistry and Laboratory Medicine
(IFCC) [39].
Psychological and behavioral questionnaires
Participants will complete the following questionnaires at
entry to the study, at discharge from the hospital and at 3,
6 and 12-month follow-up time points by postal mail,
Differently, the Outcome Questionnaire will be adminis-
tered electronically through the web-platform before
each videoconference session with the clinical psycholo-
gist.
The Self-Report Habit Index (SRHI) - Italian translation
The SRHI is a measure of the development and strength
of habits. It has a stem " [the behavior] is something that
..." followed by 12 items such as "I do without thinking'.
The SHRI has high internal consistency (α > 0.9), high
test-retest reliability (r = 0.91) and high convergent and
discriminative validity [40]. In our study, behaviors are:
"eating in accordance with the prescribed diet" and
"undertaking regular physical activity".
Weight Efficacy Life Style Questionnaire (WELSQ) - Italian 
version
The WELSQ is composed of 20 items that measure the
confidence of the subjects about being able to success-
fully resist the desire to eat. The questionnaire was used
to predict both weight loss and weight loss maintenance
across a range of ages in men and women [21].
Body Uneasiness Test (BUT) - Italian version
The BUT is a self-report inventory that measures body
uneasiness by a global severity index and five sub-scales:
Weight Phobia, Body Image Concerns, Avoidance, Com-
pulsive Self-Monitoring, Depersonalization [41].
Binge Eating Scale (BES) - Italian version
The BES is a short self-report questionnaire which mea-
sures severity of binge eating [42]. The Italian version of
the instrument [43] consists of 16 items, which are com-
posed by three or four sentences about the severity of
binge eating. Cut-off score for mild binge eating symp-
toms is 17; scores between 18-26 indicate moderate binge
eating symptoms and scores over 27 can be associated
with a severe binge eating disturbance.
Eating Disorder Inventory (EDI-2) - Italian version
The EDI-2 is a widely used, standardized, self-report
measure of psychological symptoms commonly associ-
ated with anorexia nervosa, bulimia nervosa and other
eating disorders. The EDI-2 does not yield a specific diag-
nosis of eating disorder. It is aimed at the measurement of
psychological traits or symptom clusters presumed to
have relevance to understanding and treatment of eating
disorders. The EDI-2 consists of 11 subscales derived
from 91 items. Three of the subscales were designed to
assess attitudes and behaviors concerning eating, weight
and shape (Drive for Thinness, Bulimia, Body Dissatisfac-
tion) and the remaining eight ones tapped more generalCastelnuovo et al. BMC Public Health 2010, 10:204
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constructs or psychological traits clinically relevant to
eating disorders (Ineffectiveness, Perfection, Interper-
sonal Distrust, Interoceptive Awareness, Maturity Fears,
Asceticism, Impulse Regulation and Social Insecurity)
[44,45].
Symptom Check List (SCL-90) - Italian version
The SCL-90 is a brief, multidimensional self-report
inventory designed to screen for a broad range of psycho-
logical problems and psychopathological symptoms. It
consists of 9 symptom scales (Somatization, Obsessive-
Compulsive, Interpersonal Sensitivity, Depression, Anxi-
ety, Hostility, Phobic Anxiety, Paranoid Ideation and Psy-
choticism) and 3 global indices [46].
Impact of Weight on Quality of Life-Lite (IWQOL-Lite) - Italian 
version
IWQOL-Lite is the short version of the original IWQOL
and is composed by 31 items. The questionnaire is self-
report and consists of 5 scales assessing the impact of
weight on QoL-related factors such as Physical Function-
ing, Self-Esteem, Sexual Life, Public Distress and Work.
IWQOL-Lite has shown high internal consistency and
high test-retest reliability [47,48]
The Outcome Questionnaire (OQ 45.2) - Italian translation
The OQ 45.2 is an self report questionnaire developed by
Michael Lambert in 1996 [35]. The OQ 45 items version
is a measure of outcome and it is designed in order to col-
lect repeated measures of patient progress during therapy
and after its conclusion. This instrument is one of the
most used in psychotherapy research in the U.S. [49]. The
OQ 45.2 is composed by 45 items that form 3 scales:
Symptom Distress (SD), Interpersonal Relations (IR) e
Social Role (SR), and a Global Index.
Statistical analysis
Descriptive statistics (means ± SD, or median and inter-
quartile ranges, as appropriate) will be used to describe
the study sample with regard to baseline characteristics.
Before selecting the most appropriate statistical tests,
assumptions for parametric analyses will be checked.
R e p e a t e d - m e a s u r e  A N C O V A  w i l l  b e  u s e d  i n  o r d e r  t o
evaluate the effects of the intervention when data do not
violate the parametric assumptions. The mean differ-
ences between intervention and control group with 95%
confidence intervals will be calculated. Analyses will be
adjusted for possible confounders such as gender and age.
Also effect modification will be investigated using inter-
action terms between intervention group and gender and
age, respectively. If data violate parametric assumptions,
we will use the exact methods with Monte Carlo approxi-
mation, a series of non-parametric statistical algorithms
that enable researchers to make reliable inferences when
data are sparse, heavily tied or unbalanced, not normally
distributed, or fail to meet any of the underlying assump-
tions necessary for reliable results using the standard
asymptotic method [50]. The Mann-Whitney test with
Monte Carlo approximation will be used for independent
measures, the Wilcoxon rank-sum test for repeated mea-
sures and the Fisher exact test for categorical variables.
Weight data will be analyzed with an intention-to-treat
(ITT) approach with dropouts assumed to have regained
0,3 kg per month, an assumption already used in previous
studies [12,51]. Differently, missing data in the other vari-
ables will be replaced with baseline observation carried
forward (BOCF) or last observation carried forward
(LOCF) as appropriate, assuming no improvement for
non-responders patients. Odds ratios with 95% confi-
dence intervals will be also calculated at each follow-up
time-point with respect to: 1) the percentage of partici-
pants maintaining or improving weight lost at discharge
and 2) the percentage gaining a 5% and a 10% of baseline
weight reduction for the TECNOB group in comparison
with the control group. Finally, logistic regression will be
used in order to find out predictors of treatment success
defined as weight loss maintenance at the final follow-up
time-point.
A confirmatory statistical test with alpha = 0,05 two-
sided will be used for the primary outcome (weight loss in
Kilograms), whereas explorative statistical tests will be
used for all the secondary outcomes. Given the explor-
atory feature of the latter tests, critical alpha will be main-
tained at 0,05 two-sided without any correction for
multiple comparisons.
All data analyses will be performed using the Statistical
Package for the Social Sciences (version 12.0; SPSS, Inc.,
Chicago, IL).
Discussion
The TECNOB program will be evaluated in a random-
ized controlled trial. We will test the effectiveness of this
stepped down program enhanced by telecare on weight
loss, weight loss maintenance, energy expenditure, gly-
cated hemoglobin, binge eating, self-efficacy in eating
and weight control, body satisfaction, healthy habit for-
mation, disordered eating-related behaviors and cogni-
tions, psychopathological symptoms and weight-related
quality of life. Furthermore, we will explore the key
behavioral and psychological variables predictive of treat-
ment success and thus define the type of patients that
benefit the most from such an intervention.
The theoretical approach behind the TECNOB pro-
gram is to "move the healthcare where it really needs"
using an advanced telemedicine web-platform and
mobile phones to ensure the continuity of care at home.
The core value of the program is overall the clinical use of
mobile devices in the out-patients' everyday life. Indeed,
the mobile connectivity can extend the treatment till the
real-life environments of each patient, where traditional
interventions typically fails because of the low compli-Castelnuovo et al. BMC Public Health 2010, 10:204
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ance many obese patients have in carrying on with diet
programs without active monitoring and support. Fur-
thermore, mobile phones allow patients to receive "clini-
cally oriented" SMS (such as food images indicating their
day diet) that improve the reliability of the nutritional
prescriptions. The results of this study will contribute to
the evidence-based knowledge of how telemedicine may
enhance the long-term efficacy of clinical interventions
for weight loss and which type of obese patients may ben-
efit the most from such an intervention. Results will also
have an impact on the theoretical model behind the tradi-
tional health care service and, if positive, will promote a
change towards a new "health care everywhere"
approach.
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